Sign up USA
Proactive Investors - Run By Investors For Investors

Nu Skin gives profits guidance a face-lift

The uplift to guidance was made ahead of an investor day held by the wellness company
Beauty product
Looking good ... the outlook, that is

Beauty products provider Nu Skin Enterprises Inc (NYSE:NUS) raised its earnings and sales outlooks on Thursday ahead of an investors meeting.

The company had previously issued guidance to expect earnings per share of between 71 to 76 cents, but has raised the bottom end of this range to 74 cents.

Revenue is now expected to fall within the range US$559mln to US$563mln, compared to US$540mln to US$560mln previously.

Despite the uplift, the shares opened three cents lower at US$62.77. 

View full NUS profile View Profile

Nu Skin Enterprises Timeline

Related Articles

lab
March 15 2018
Amryt's lead drug candidate, AP101, is a potential treatment for epidermolysis bullosa, a rare genetic skin disorder for which there is currently no approved treatment
researcher filling a vial
April 23 2018
2018 is shaping up to be a crucial year for the company's drug pipeline
Vial of pills
May 17 2018
Cosmos is a modern company, but the trade routes it relies on are ancient
Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use